Latest News about BMRN
Recent news which mentions BMRN
Looking Into Biomarin Pharmaceutical's Recent Short Interest
April 03, 2024
Tickers
BMRN
From Benzinga
From Motley Fool
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
From InvestorPlace
3 No-Brainer Stocks to Buy With $200 Right Now
February 07, 2024
From Motley Fool
Decoding 8 Analyst Evaluations For Biomarin Pharmaceutical
January 30, 2024
Tickers
BMRN
From Benzinga
4 Marvelous Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
January 20, 2024
From Motley Fool
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
January 10, 2024
From InvestorPlace
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
December 02, 2023
From Motley Fool
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
November 09, 2023
From InvestorPlace
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
From InvestorPlace
Tickers
BMRN
From InvestorPlace
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
November 07, 2023
From Benzinga
4 Unique Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
November 04, 2023
From Motley Fool
Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?
October 27, 2023
From Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2023
October 19, 2023
From Motley Fool
15 Analysts Have This to Say About Biomarin Pharmaceutical
October 16, 2023
Tickers
BMRN
From Benzinga
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
September 28, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
From Benzinga
4 Awe-Inspiring Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 23, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
September 18, 2023
From Benzinga
Investors should stick to the ‘late cycle playbook’ and buy these sectors, says Morgan Stanley’s Mike Wilson
September 18, 2023
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2023
From Benzinga
What 16 Analyst Ratings Have To Say About Biomarin Pharmaceutical
September 13, 2023
Tickers
BMRN
From Benzinga
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 02, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.